EBOS Group Limited (ASX:EBO)

Australia flag Australia · Delayed Price · Currency is AUD
36.53
-0.27 (-0.73%)
Jul 18, 2025, 4:11 PM AEST
18.26%
Market Cap7.41B
Revenue (ttm)12.60B
Net Income (ttm)245.86M
Shares Outn/a
EPS (ttm)1.27
PE Ratio30.14
Forward PE25.40
Dividend1.13 (3.09%)
Ex-Dividend DateFeb 27, 2025
Volume23,624
Average Volume93,108
Open36.79
Previous Close36.80
Day's Range36.45 - 36.93
52-Week Range30.72 - 38.09
Beta0.26
RSI58.44
Earnings DateAug 27, 2025

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ... [Read more]

Sector Healthcare
Founded 1922
Employees 4,963
Stock Exchange Australian Securities Exchange
Ticker Symbol EBO
Full Company Profile

Financial Performance

In 2024, EBOS Group's revenue was 13.19 billion, an increase of 7.78% compared to the previous year's 12.24 billion. Earnings were 271.55 million, an increase of 7.17%.

Financial Statements

News

UBS launches $NZ217m EBOS Group placement to fund acquisitions

New shares were priced at $NZ36.65 – a 5 per cent discount to the last close price.

3 months ago - The Australian Financial Review

Ebos Group Ltd (EBOSF) (Q1 2025) Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...

Ebos Group Ltd (EBOSF) (Q1 2025) Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments

5 months ago - GuruFocus

Half Year 2025 EBOS Group Ltd Earnings Call Transcript

Half Year 2025 EBOS Group Ltd Earnings Call Transcript

5 months ago - GuruFocus